Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Forsyth

Showing results (291-300 of 406) with videos related to

Pageof 41
Sort By:
Journal of Neuro-Oncology|May 20, 2006
A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant gliomaP Tang, G Roldan, P M A Brasher, et al.
Clinical Neurology and Neurosurgery|April 7, 2017
Clinical outcomes from maximum-safe resection of primary and metastatic brain tumors using awake craniotomyAnastasia Groshev, Devang Padalia, Sephalie Patel, et al.
Drug and Alcohol Dependence|October 1, 1991
Scottish cocaine users: wealthy snorters or delinquent smokers?J Ditton, K Farrow, A Forsyth, et al.
The Journal of Organic Chemistry|October 25, 2001
Quararibea Metabolites. 4.(1) Total Synthesis and Conformational Studies of (+/-)-Funebrine and (+/-)-FunebralYing Dong, Niranjan Niranjan N Pai, Sheri L. Ablaza, et al.
The Journal of Continuing Education in the Health Professions|March 5, 2003
Randomized controlled trials of continuing medical education: what makes them most effective?Joy Garrison Cauffman, Roger A Forsyth, Virginia A Clark, et al.
Investigational New Drugs|August 14, 2012
REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumorsDon G Morris, Xiaolan Feng, Lisa M DiFrancesco, et al.
Journal of Neurosurgery|May 1, 1993
Intracranial chordomas: a clinicopathological and prognostic study of 51 casesP A Forsyth, T L Cascino, E G Shaw, et al.
Plos One|June 14, 2013
Resistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferonFranz J Zemp, Brienne A McKenzie, Xueqing Lun, et al.
Journal of Neurosurgery|March 1, 1995
Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful?P A Forsyth, P J Kelly, T L Cascino, et al.
Journal of Clinical Pathology|September 29, 2005
IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest in breast carcinomaR Ainsworth, J M S Bartlett, J J Going, et al.
Pageof 41

Showing results (291-300 of 406) with videos related to

Sort By:
Pageof 41
Journal of Neuro-Oncology|May 20, 2006
A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant gliomaP Tang, G Roldan, P M A Brasher, et al.
Clinical Neurology and Neurosurgery|April 7, 2017
Clinical outcomes from maximum-safe resection of primary and metastatic brain tumors using awake craniotomyAnastasia Groshev, Devang Padalia, Sephalie Patel, et al.
Drug and Alcohol Dependence|October 1, 1991
Scottish cocaine users: wealthy snorters or delinquent smokers?J Ditton, K Farrow, A Forsyth, et al.
The Journal of Organic Chemistry|October 25, 2001
Quararibea Metabolites. 4.(1) Total Synthesis and Conformational Studies of (+/-)-Funebrine and (+/-)-FunebralYing Dong, Niranjan Niranjan N Pai, Sheri L. Ablaza, et al.
The Journal of Continuing Education in the Health Professions|March 5, 2003
Randomized controlled trials of continuing medical education: what makes them most effective?Joy Garrison Cauffman, Roger A Forsyth, Virginia A Clark, et al.
Investigational New Drugs|August 14, 2012
REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumorsDon G Morris, Xiaolan Feng, Lisa M DiFrancesco, et al.
Journal of Neurosurgery|May 1, 1993
Intracranial chordomas: a clinicopathological and prognostic study of 51 casesP A Forsyth, T L Cascino, E G Shaw, et al.
Plos One|June 14, 2013
Resistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferonFranz J Zemp, Brienne A McKenzie, Xueqing Lun, et al.
Journal of Neurosurgery|March 1, 1995
Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful?P A Forsyth, P J Kelly, T L Cascino, et al.
Journal of Clinical Pathology|September 29, 2005
IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest in breast carcinomaR Ainsworth, J M S Bartlett, J J Going, et al.
Pageof 41